Showing results (201-210 of 270) with videos related to

Sort By:
Pageof 27
Cancer Research|July 1, 2021
Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer ImmunityLaura Seclì, Lidia Avalle, Pietro Poggio, et al.
European Journal of Neurology|September 9, 2022
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-upMattia Parisi, Irene Dogliotti, Michele Clerico, et al.
Breast Cancer Research : BCR|January 24, 2014
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2Carla De Giovanni, Giordano Nicoletti, Elena Quaglino, et al.
Pharmaceutics|July 28, 2026
Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast CancerJunbiao Wang, Alessia Lamolinara, Daniele Tomassoni, et al.
Frontiers in Immunology|August 22, 2025
Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomesAlberto Mella, Roberta Clari, Valeria Deiana, et al.
American Journal of Hematology|May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European studyPatrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Blood|May 29, 2008
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trialAntonio Palumbo, Sara Bringhen, Anna M Liberati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2014
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNAFederica Riccardo, Selina Iussich, Lorella Maniscalco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyMarco Ladetto, Daniela Drandi, Mara Compagno, et al.
Journal of Geriatric Oncology|July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana LinfomiFrancesco Merli, Federica Cavallo, Flavia Salvi, et al.
Pageof 27